<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">477070779</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180405111424.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170330e19961001xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/BF01701519</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/BF01701519</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Epidemiology of community-acquired Pseudomonas aeruginosa infections in children</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[I. Paraskaki, E. Lebessi, N. Legakis]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">The epidemiology of community-acquiredPseudomonas aeruginosa infections in children during a one-year period (January through December 1993) was evaluated. A total of 6,859 clinical samples, each one representing a separate individual with suspected infection, were cultured.Pseudomonas aeruginosa was isolated from 218 children with various infections occurring in the following order of frequency: chronic suppurative otitis media, 76.3%; appendicitis/peritonitis, 10.3%; osteomyelitis, 8.9%; skin or soft tissue infection, 6.3%; acute conjunctivitis, 3.0%; and urinary tract infection, 0.1%. A variety of O serogroups were identified: O1 (15.2%), 06 (14.7%), O11 (12.4%), O10 (11.5%), O3 (10.6%), O5 (5.1 %), and O9 (4.6%). Other serogroups and nontypable strains were recovered at a frequency of 11.2% and 14.7%, respectively. Nontypable strains predominated in chronic otitis media (18.9%), while serogroups O1 (18.3%), O6 (17.5%), and O11 (17.5%) were recovered most frequently among the typable isolates. Susceptibility ofPseudomonas aeruginosa to antipseudomonadal agents was extremely high. The rate of susceptibility to ceftazidime was 99.6%, to azlocillin 98.6%, to piperacillin 98.2%, to aztreonam 97.3%, to gentamicin and netilmicin 97.7%, and to ciprofloxacin 99.1%. All isolates were susceptible to tobramycin, imipenem, and amikacin. The results might suggest that community-acquiredPseudomonas aeruginosa infections in children can be treated successfully with any antipseudomonadal antibiotic.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer-Verlag, 1996</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Paraskaki</subfield>
   <subfield code="D">I.</subfield>
   <subfield code="u">Microbiology Department of &quot;P. and A. Kyriakou” Children's Hospital, University of Athens, M. Asias 75, 115 27, Goudi, Athens, Greece</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Lebessi</subfield>
   <subfield code="D">E.</subfield>
   <subfield code="u">Microbiology Department of &quot;P. and A. Kyriakou” Children's Hospital, University of Athens, M. Asias 75, 115 27, Goudi, Athens, Greece</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Legakis</subfield>
   <subfield code="D">N.</subfield>
   <subfield code="u">Department of Microbiology, Medical School, University of Athens, M. Asias 75, 115 27, Goudi, Athens, Greece</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">European Journal of Clinical Microbiology and Infectious Diseases</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">15/10(1996-10-01), 782-786</subfield>
   <subfield code="x">0934-9723</subfield>
   <subfield code="q">15:10&lt;782</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">15</subfield>
   <subfield code="o">10096</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/BF01701519</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/BF01701519</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Paraskaki</subfield>
   <subfield code="D">I.</subfield>
   <subfield code="u">Microbiology Department of &quot;P. and A. Kyriakou” Children's Hospital, University of Athens, M. Asias 75, 115 27, Goudi, Athens, Greece</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Lebessi</subfield>
   <subfield code="D">E.</subfield>
   <subfield code="u">Microbiology Department of &quot;P. and A. Kyriakou” Children's Hospital, University of Athens, M. Asias 75, 115 27, Goudi, Athens, Greece</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Legakis</subfield>
   <subfield code="D">N.</subfield>
   <subfield code="u">Department of Microbiology, Medical School, University of Athens, M. Asias 75, 115 27, Goudi, Athens, Greece</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">European Journal of Clinical Microbiology and Infectious Diseases</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">15/10(1996-10-01), 782-786</subfield>
   <subfield code="x">0934-9723</subfield>
   <subfield code="q">15:10&lt;782</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">15</subfield>
   <subfield code="o">10096</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
